About
Iqbal Mufti is an Operating Partner at SR One Capital Management, based in London, where he focuses on company creation, later-stage investments, and helping portfolio companies with industry engagement and partnering strategy. He previously worked as a pharmaceutical executive at Hoffmann-La Roche, where he co-led the rare blood disorders portfolio strategy team and served as global Lifecycle Leader for Hemlibra (emicizumab). He holds a BSc in Biotechnology from University College London and an MBA from Duke University's Fuqua School of Business.
Invests in
Biotech
Experience
- SR One Capital ManagementVenture Partnercurrent2022 — presentLondon, England, United Kingdom / Basel, Switzerland
- Windward BioBoard Membercurrent2025 — presentBasel, Basel, Switzerland
- Econic BiosciencesBoard Membercurrent2025 — presentLondon, England, United Kingdom
- Antag TherapeuticsBoard Observercurrent2024 — presentCopenhagen, Denmark
- CORXEL PharmaceuticalsBoard Observercurrent2026 — presentNew York, New York, United States
- Vibrant Biomedicines, Inc.Board Member2024 — 2025Boston, Massachusetts, United States
- RocheCo-Lead Disease Area Strategy Team - Rare Blood Disorders Franchise2020 — 2022Basel, Switzerland
- RocheLifecycle Leader - Haemophilia (Hemlibra)2019 — 2022Basel, Basel, Switzerland
- RocheIntegrated Strategy Leader - Haemophilia (Hemlibra)2018 — 2019Basel, Basel, Switzerland
- RocheCommercial Director (Global Commercial Head - Hemlibra)2018Basel, Basel, Switzerland
- RocheInternational Business Leader - Haemophilia2016 — 2018Basel, Basel, Switzerland
- RocheBusiness Unit Head - Sales & Marketing2015 — 2016Egypt
- Roche / GenentechGlobal Head Strategic Partnering - Ad Interim2014South San Francisco
- Roche / GenentechGlobal Business Development Director - Strategic Partnering2011 — 2014South San Francisco
- Hoffmann-La RocheGlobal Business Development Director, Strategic Partnering2010 — 2011New Jersey
- Hoffmann-La RocheGlobal Business Development Manager - Commercial Assessment2008 — 2010
- Roche PharmaceuticalsDirector - Commercial Operations2004 — 2007
Education
- Duke University - The Fuqua School of BusinessMBA2000 — 2002
- UCLBSc Hons, Biotechnology1993 — 1996
Skills & more
Strategic Partnerships21Biotechnology32Lifesciences6Oncology13Drug Development7Biopharmaceuticals23Clinical Development6Pharmaceutical Industry30
From Iqbal's professional profile.
Same school
Also attended Duke University - The Fuqua School of Business165
David BlivinMANAGING PARTNER at Cottonwood Technology FundVinnie McSweeneyInvestor at OpenView Venture PartnersBrooke BalcomBoard Member at CincyTechChad L. SummeBoard Member at CincyTechMatias BarberoVenture Partner at FJ LabsTracie RotterPartner, Platform at Lux Capital
+ 159 more
Shared employers
Also worked at Antag Therapeutics4
Also worked at CORXEL Pharmaceuticals1
Also worked at Roche73
Joseph HorsmanInvestor at Madrona Venture GroupMarco PrunottoInvestor at MedicxiMike FitzgeraldInvestor at High AlphaUri LopatinInvestor at Khosla VenturesJan-Olivier FillolsSenior Managing Director at Marlin Equity PartnersNarges BaniasadiVenture Partner at Think+ Ventures Management, Llc
+ 67 more
Also worked at Roche / Genentech89
David SchenkeinInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Marco PrunottoInvestor at MedicxiLogan HilleLife Sciences Analyst at CincyTechJosephine ChenInvestor at Sequoia CapitalAbbie CelnikerInvestor at Third Rock Ventures
+ 83 more
Colleagues at SR One Capital Management
Alicia Hasson
Executive Assistant at SR One Capital Management
Amit Mehta
Venture Partner - US Investments at SR One Capital Management
Amit Shah
Principal at SR One Capital Management
Ann Ng
Finance Director at SR One Capital Management
Brian Gallagher
Partner at SR One Capital Management
Briana Wilson
Senior Administrative Assistant at SR One Capital Management
Catalina Kazi
Legal & Compliance Counsel at SR One Capital Management
Chris Chai
Operating Partner - Portfolio Capital Raising at SR One Capital Management


































